Cidofovir inhibits growth of B16 melanoma cells in vivo

British Journal of Dermatology

Volumn 143, Issue 4, 2000, Pages 741-748

  Redondo, P ^a   Idoate, M ^a   Galofre J C ^a   Solano, T ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Antitumoral effect; Antiviral; Cidofovir; Melanoma cells

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CIDOFOVIR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CYTOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SKIN NEOPLASMS;

EID: 0033752940     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03769.x     Document Type: Article

References (33)

1. Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (ie, herpes-, papova-, pox- and adenovirus) infections
2. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation
3. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine, a potent and selective inhibitor of human cytomegalovirus replication
4. Intracellular metabolism of the antiherpes agent (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine
5. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
6. Successful treatment of a squamous papilloma of the hypopharynx-oesophagus by local injection of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine
7. The antiviral agent cidofovir (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine) has pronounced activity against nasopharyngeal carcinoma grown in nude mice
8. HPMPC (cidofovir), PMEA (adefovir), and related acyclic nucleoside phosphonate analogues: A review of their pharmacology and clinical potential in the treatment of viral infections
9. Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir
10. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
11. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents
12. Increased invasion and spontaneous metastasis of B16 melanoma with inhibition of the desmoplastic response in C57BL/6 mice
13. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds
14. Abatement of cutaneous Kaposi's sarcoma associated with cidofovir therapy
15. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
16. Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: Case report
17. Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue
18. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine)
19. Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir
20. Topical cidofovir for severe molluscum contagiosum
21. Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects
22. Pharmacokinetics of cidofovir in monkeys: Evidence for a prolonged elimination phase representing phosphorylated drug
23. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir
24. Treatment of severe recurrent laryngeal papillomatosis by local injections of (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl) cytosine (cidofovir)
25. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial
26. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys
27. Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients
28. Cidofovir: Induction of apoptosis in human papilloma virus (HPV) -containing cell lines. Tenth International Conference on Antiviral Researh, Atlanta, GA, U.S.A., 6-11 April 1997
29. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV) -harboring cell lines compared with HPV-negative cell lines
30. Antitumor potential of acyclic nucleoside phosphonates
31. Characteristics of cancer death after exposure to cytotoxic drugs in vitro
32. Conversion of 1-(S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl) methyl) cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase